scholarly article | Q13442814 |
P356 | DOI | 10.1016/0014-2999(85)90493-5 |
P698 | PubMed publication ID | 2992993 |
P2093 | author name string | Takemori AE | |
Ahlijanian MK | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sensory perception of pain | Q2734305 |
P304 | page(s) | 171-179 | |
P577 | publication date | 1985-06-01 | |
P1433 | published in | European Journal of Pharmacology | Q1376712 |
P1476 | title | Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice | |
P478 | volume | 112 |
Q52172675 | Adenosine A(2) receptors inhibit morphine self-administration in rats. |
Q28298915 | Adenosine A(2A) receptors and their role in drug addiction |
Q24676705 | Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain |
Q36083482 | Adenosine and brain function |
Q44563613 | Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity |
Q48826689 | Adenosine modulation: a novel approach to analgesia and inflammation |
Q43070892 | Adenosine receptor activation and nociception |
Q71350111 | Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs |
Q89317488 | Antinociceptive Effect of Racemic Flurbiprofen and Caffeine Co-Administration in an Arthritic Gout-Type Pain in Rats |
Q41771392 | Anxiolytic activity of adenosine receptor activation in mice |
Q28338174 | Binary drugs: conjugates of purines and a peptide that bind to both adenosine and substance P receptors |
Q72021910 | Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms |
Q73302947 | Central adenosine A(2A) receptors: an overview |
Q41841691 | Classification of adenosine receptors mediating antinociception in the rat spinal cord |
Q67701864 | Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine |
Q47569719 | Effect of adenosine analogues on the expression of opiate withdrawal in rats |
Q43331943 | Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats |
Q28181287 | Effect of caffeine on antinociceptive action of ketoprofen in rats |
Q42261176 | Effect of potassium channel modulators on morphine withdrawal in mice |
Q77329261 | Effects of adenosine receptor agents on the expression of morphine withdrawal in mice |
Q52049242 | Effects of purine analogues on spontaneous alternation in mice. |
Q44225339 | Formalin-induced pain and mu-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice |
Q38049629 | Hypnic headache and caffeine |
Q46917514 | Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives |
Q37791048 | Methylxanthines and Pain |
Q36476253 | Opiate-induced changes in brain adenosine levels and narcotic drug responses |
Q26782928 | Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics |
Q52056582 | Prospective role for adenosine and adenosinergic systems in psychiatric disorders. |
Q43713765 | Pyridopyrimidine analogues as novel adenosine kinase inhibitors |
Q44044472 | Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains and spinal cords of mice deficient in the mu-opioid receptor gene. |
Q35045491 | Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice. |
Q54027566 | Role of ATP-sensitive K+ channels in antinociception induced by R-PIA, an adenosine A1 receptor agonist. |
Q73419036 | Studies investigating the possible involvement of adenosine in the antisecretory action of morphine |
Q46235675 | The adenosine agonist NECA inhibits intestinal secretion and peristalsis |
Q34074761 | Therapeutic potential of adenosine kinase inhibitors |
Search more.